# Effects of Dexmedetomidine on Patients With Coronary Heart Disease After Percutaneous Coronary Intervention

> **NCT03095469** · EARLY_PHASE1 · UNKNOWN · sponsor: **First Affiliated Hospital Xi'an Jiaotong University** · enrollment: 200 (estimated)

## Conditions studied

- Heart Injuries

## Interventions

- **DRUG:** Dexmedetomidine
- **DRUG:** 0.9%NaCl solution

## Key facts

- **NCT ID:** NCT03095469
- **Lead sponsor:** First Affiliated Hospital Xi'an Jiaotong University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-08-20
- **Primary completion:** 2017-11-30
- **Final completion:** 2017-12-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2017-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03095469

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03095469, "Effects of Dexmedetomidine on Patients With Coronary Heart Disease After Percutaneous Coronary Intervention". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03095469. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*